AIRA Sciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.68M

  • Investors
  • 3

AIRA Sciences General Information

Description

Developer of a spectral analytics and multi-cancer screening platform designed to transform early cancer detection. The company's platform utilizes spectral analytics and diagnostic algorithms to provide non-invasive multi-cancer screening, accessible test processing, and simplified clinical reporting, enabling healthcare providers and diagnostic laboratories to manage early detection through a centralized digital interface.

Contact Information

Formerly Known As
BeamLine Diagnostics, DynamX
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ketton Suite, The King Centre, Main Road
  • Barleythorpe, Oakham
  • Rutland LE15 7WD
  • England, United Kingdom
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Corporate Office
  • Ketton Suite, The King Centre, Main Road
  • Barleythorpe, Oakham
  • Rutland LE15 7WD
  • England, United Kingdom

AIRA Sciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AIRA Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 31-Jul-2026 $1.68M Completed Generating Revenue
5. Early Stage VC 01-Jun-2025 Completed Generating Revenue
4. Grant 01-Dec-2022 Completed Generating Revenue
3. Early Stage VC 01-Nov-2022 Completed Generating Revenue
2. Grant 01-Jun-2021 $1.71M Completed Generating Revenue
1. Grant 06-Jan-2021 $894K Completed Generating Revenue
To view AIRA Sciences’s complete valuation and funding history, request access »

AIRA Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 2,878 $0.000001 $23.24 $23.24 1x $23.24 0.2%
Ordinary 17,802 $0.000001 $9.39 $9.39 1x $9.39 1.23%
To view AIRA Sciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AIRA Sciences Patents

AIRA Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-3018586-T3 Lung cancer screening procedure Active 15-Nov-2019
CA-3157751-A1 Method for detecting lung cancer Pending 15-Nov-2019
EP-4058784-A1 Method for detecting lung cancer Active 15-Nov-2019
EP-4058784-B1 Method for detecting lung cancer Active 15-Nov-2019
EP-4058784-C0 Method for detecting lung cancer Active 15-Nov-2019 G01N15/1456
To view AIRA Sciences’s complete patent history, request access »

AIRA Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AIRA Sciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Golden Section Venture Capital Minority
Innovate UK Government
To view AIRA Sciences’s complete investors history, request access »

AIRA Sciences FAQs

  • When was AIRA Sciences founded?

    AIRA Sciences was founded in 2021.

  • Where is AIRA Sciences headquartered?

    AIRA Sciences is headquartered in Rutland, United Kingdom.

  • What is the size of AIRA Sciences?

    AIRA Sciences has 5 total employees.

  • What industry is AIRA Sciences in?

    AIRA Sciences’s primary industry is Other Healthcare Technology Systems.

  • Is AIRA Sciences a private or public company?

    AIRA Sciences is a Private company.

  • What is the current valuation of AIRA Sciences?

    The current valuation of AIRA Sciences is .

  • What is AIRA Sciences’s current revenue?

    The current revenue for AIRA Sciences is .

  • How much funding has AIRA Sciences raised over time?

    AIRA Sciences has raised $2.9M.

  • Who are AIRA Sciences’s investors?

    European Innovation Council, Golden Section, and Innovate UK have invested in AIRA Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process